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Gold nanoclusters (Au NCs) are an emerging type of theranostic agents combining
therapeutic and imaging features with reduced toxicity. Au NCs stabilized by a zwitte-
rion ligand with a fine control of the metal core size and the ligand coverage were syn-
thesized by wet chemistry. Intense fluorescence signal is reported for the highest ligand
coverage, whereas photoacoustic signal is stronger for the largest metal core. The best
Au NC candidate with an average molecular weight of 17 kDa could be detected with
high sensitivity on a 2D-near-infrared imaging instrument (limit of detection (LOD)
= 2.3 µM) and by photoacoustic imaging. In vitro and in vivo experiments demonstrate
an efficient cell uptake in U87 cell lines, a fast renal clearance (t1/2α = 6.5 ± 1.3 min),
and a good correlation between near infrared fluorescence and photoacoustic mea-
surements to follow the early uptake of Au NCs in liver. © 2017 Author(s).
All article content, except where otherwise noted, is licensed under a Creative
Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
[http://dx.doi.org/10.1063/1.4977203]
The sub-class of nanoclusters (NCs) in a wide library of metal nanoparticles has found a growing
interest over the last few years for in vivo studies notably for cancer applications. Those metal
NCs, mainly gold, are made of ten to hundred atoms and usually presented as species filling the
gap between molecules and nanoparticles.1–4 Gold nanoclusters (Au NCs) present several features
making them appealing for cancer therapy thanks to (i) their high renal clearance5,6 reducing toxicity
risk, (ii) the relatively high tumor retention by passive uptake,7,8 (iii) the ability to trigger cell death
under light illumination9 or radiosensitization,10–12 and (iv) the detection by multimodal imaging
techniques.13–15
In optical imaging, one of the great advantages of Au NCs compared to plasmonic Au nanoparti-
cles (Au NPs) is related to the ability to visualize them by fluorescence in the red-near-infrared (NIR)
region (650-800 nm), a spectral window suitable for in vivo studies due to the reduced tissue scat-
tering and low blood absorption.16,17 In addition, the high electronic number of gold (Z = 79) allows
the detection of gold particles by computed X-ray tomography (CT)5 and by photoacoustic imaging
(PAI).18,19 With the development of new contrast agents such as gold nanorods and nanocages, PAI
combines the most compelling features of optical imaging and ultrasound imaging, providing both
high optical contrast and high resolution ultrasound including in vivo in deep tissues.20–22
Au NCs stabilized by glutathione (GSH) are probably one of the most described NCs in the
literature with a precise control of their size and their structure.23–26 The natural peptide GSH has
a zwitterionic structure and, when coated on the particle surface, could prevent the detection by
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macrophages.27 Recently, we investigated the optical properties and the behavior in cell environment
of Au NCs stabilized by bidentate thiol zwitterionic ligand (Zw) have been recently reported showing
a high colloidal stability and an intense fluorescence emission tunable in the near-infrared region .28–30
In this study, we aimed to determine the influence of the core size and the ligand coverage of
gold particle to their fluorescence and their photoacoustic signals. For this purpose, gold particles of
different sizes from the small plasmonic NPs (i.e., size∼4 nm) to NCs (i.e., size< 2.5 nm) stabilized by
a zwitterion ligand were prepared. Then, we investigated the behavior of the best candidate exhibiting
both high fluorescence and photoacoustic signals in cells and in mice. Additional information is also
reported on the NC size determined by mass spectrometry for Au NCs stabilized by a zwitterionic
ligand.
All products were purchased from Sigma Aldrich and MilliQ (Millipore, France) water was used
for all experiments.
Thioctic-zwitterion (Zw, C15H30N2O4S3, M∼399 g mol1) was synthesized following the pro-
tocol described elsewhere.28 Au NCs with zwitterion (Au:Zw) were prepared by the addition of gold
salt (HAuCl4.3H2O, 50 mM) to a basic solution (pH 10) containing the ligand in the presence of
the strong reducing agent NaBH4 (50 mM) and stirred for 15 h. Zwitterion stabilized Au NCs were
synthesized with the molar ratio Au:Zw:NaBH4 = 1:1:2, 1:2:2, and 1:5:2. Zwitterion stabilized Au
NPs were synthesized with the molar ratio Au:Zw:NaBH4 = 2:1:2 and 5:1:2. Afterwards, solutions
were filtered twice with Amicon 3 kDa cut-off filters at 13 600 rpm for 20 min to remove excess
free ligands, adjusted to pH 7, concentrated to 5 mg gold/ml in water, and kept refrigerated until
use.
Protected Au25GSH18 clusters were synthesized in two steps as described by Pradeep and co-
workers.31 Briefly, in a first step, the complex formed between HAuCl4 and glutathione GSH (Au:GSH
= 1:4) was reduced in a methanolic solution (0 ◦C) with NaBH4. The resulting precipitate (Au@SG)
was washed with methanol and dried. In a second step, Au@SG was dissolved in water with 1 mM
of GSH and heated at 55 ◦C for 12 h. The solution was centrifuged and Au25GSH18 is precipitated
from the supernatant by adding methanol. The precipitate was washed several times with methanol
before drying in vacuum.
Transmission electron microscopy (TEM) images of the NCs and NPs were measured on a FEI
Tecnai G2 Twin TEM. XPS investigation was performed in a K-Alpha+ spectrometer (ThermoFisher
Scientific) using a microfocused, monochromated Al Kα X-ray source (400 µM spot size). The
spectra were fitted with one or more Voigt profiles (binding energy uncertainty:±0.2 eV) and Scofield
sensitivity factors were applied for quantification.32 All spectra were referenced to the C1s peak at
285.0 eV binding energy (C–C, C–H) and controlled by means of the well-known photoelectron
peaks of Cu, Ag, and Au, respectively. Measurements were performed at two different locations of
dried samples. Evolution of the Au NC size as a function of the metal–ligand ratio was determined
by electrospray ionization (ESI) on a commercial quadrupole time-of-flight (micro-qTOF, Bruker-
Daltonics, Bremen, Germany, mass resolution ∼10 000). The samples were prepared by diluting the
mother solution in water, to a final concentration of 0.25-0.5 mg ml1 in 50/50% water/meOH v/v.
The samples were analyzed in positive ion mode: each data point was the summation of spectra over
5 min. External calibration was carried out with a set of synthetic peptides.
Absorbance measurements on diluted samples were performed on an Evolution 201 (Thermo-
scientific) UV-vis spectrophotometer between 300 and 1000 nm. Fluorescence spectra were recorded
on a Perkin Elmer LS45 fluorescence spectrometer. Fluorescence imaging was performed with a NIR
2D-fluorescence reflectance imaging device (Fluobeam 800r, Fluoptics, France). The excitation is
provided by a class 1 expanded laser source at 780 nm, and the irradiance on the imaging field is
100 mW/cm2. The fluorescence signal is collected by a CCD through a high pass filter with a high
transmittance for wavelength >830 nm.
PAI was performed on The VevoLAZR system (Visualsonics, Fujifilm) using the LZ201 trans-
ducer (256 elements linear array; 9-18 MHz) allowing a 44 µM axial resolution. The laser is tunable
between 680 and 970 nm, and acquisitions can be made continuously with 1 nm steps providing a
photoacoustic spectrum.
U87MG cells were cultured in six-well plates one day before the experiment. The Au NCs were
added to the cell medium at 50 µg gold/ml (eq. 35 µM) for the indicated time (4 h to 24 h), and the
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cells were incubated at 37 ◦C or 4 ◦C. Then, the cells were resuspended with trypsin and carefully
washed in phosphate-buffered saline (PBS) before analysis. Propidium iodide was added to the cell
suspension according to the manufacturer’s instructions (BD Pharmingen, Belgium). The cells were
analyzed using LSR II (Becton Dickinson, France). The 405 nm laser was used to excite the Au NCs,
and the signal was collected after a long-pass 750 nm, at 780/60 nm. Propidium iodide was excited
at 488 nm, filtered with the long-pass 655 nm, and its emission was collected at 660/20 nm. Specific
compensations were applied to prevent the overlapping of the signals.
Six weeks old NMRI nude mice (Janvier, France) were anesthetized (air/isoflurane 4% for induc-
tion and 1.5% thereafter) and were injected intravenously via the tail vein with 200 µL of Au NCs
at 600 µM. In vivo fluorescence imaging was performed before and 1, 3, 5, and 24 h after injection.
Mice were euthanized at 1, 5, or 24 h post injection (n = 3 mice per time point) and organs were
harvested for ex vivo fluorescence imaging.
Three other mice were injected and blood samples were collected 10 s and 5, 10, 15, 20, 30, 45,
and 60 min after injection and were centrifuged (10 min at 2000 g) to separate plasma. Fluorescence
imaging was then performed on plasma samples.
For PAI, an US gel (Parker Laboratories, Inc., USA) was applied on the mouse body, the trans-
ducer was placed above the liver, and a 30 × 30 mm2 slice was imaged both in B-mode (ultrasound)
and in PA mode at 710 nm before and 1, 5, and 24 h after intravenous injection.
We choose the ligand Zw (Figure 1(a)) to produce gold particles of different sizes because this
molecule was shown to strongly improve the colloidal stability of particle33 and also to obtain Au
NCs exhibiting one the highest fluorescence intensity reported so far.28,30,34 Molar ratio Au:ligand has
been modified during the synthesis in order to play both on the final metal core size and on the ligand
coverage. Thus, a molar ratio Au > ligand leads to NP for Au:Zw = 2:1 and 5:1 and a molar ratio Au
≤ ligand leads to NCs for Au:Zw = 1:1, 1:2, and 1:5. TEM images (Figure S1 of the supplementary
material) show clearly a decrease of the metal core diameter when the amount of the ligand increases
from 4.8 ± 1.2 nm for Au:Zw 5:1 to less than 2.5 nm for Au:Zw 1:2 and Au:Zw 1:5. In the case of
Au NCs (i.e., for Au:Zw 1:1, Au:Zw 1:2, and Au:Zw 1:5), mass spectrometry is reckoned as a suited
technique to determine the full size and the structure of metal NCs.35–40 We previously attempted
to determine specific magic clusters using matrix-assisted laser desorption ionization / time of flight
(MALDI-Tof) technique on those types of NCs without any success.28 Here, the high mass setting is
optimized for the Au:Zw NCs. Au:Zw NCs contain multiple groups capable of being ionized and the
ESI source can produce highly charged ions. For those molecules that can sustain multiple charges,
a distribution of charge states is often observed in the mass-to-charge spectrum. This multiplicity of
states gives rise to an “envelope” of peaks in the spectrum. The distribution of charges is observed
in the m/z range 1000–8000 after electrospraying in positive mode water solution containing the
nanoparticles (Figure S2 of the supplementary material). Although the position of the peaks in the
mass spectra is stable, the relative abundance of the different peaks is found to be slightly dependent
on the electrospray mass spectrometry (ESI-MS) conditions. A multiplicative correlation algorithm
(MCA) is used to estimate the mass of nanoparticles from the mass-to-charge spectra produced by
electrospray ionization mass spectrometry.41 The multiplicative correlation is designed to enhance
the deconvoluted signal when the parent molecule is distributed into several charge states in the





where f (m) is the intensity calculated in the spectrum for mass m, g(m/z) is the intensity in the
mass-to charge spectrum, and grms is the root-mean-square (rms) value of the signal measured.
As the Au NCs contain multiple ionized groups (Zw ligands), a distribution of charge states
is observed in the mass-to-charge spectrum, and the MCA is used to estimate the mass of the Au
NCs from the mass-to-charge spectra produced by the ESI-MS. As seen in Figure 1(b), for Au:Zw
1:1, the distribution is centered at 11 000 Da with a second distribution (with a smaller intensity) at
∼13 500 Da. For Au:Zw 1:2, the mass increased to 17 200 Da (with a second distribution with a
smaller intensity at ∼13 600 Da). For Au:Zw 1:5, the mass reached to 32 850 Da (with a second dis-
tribution at ∼30 660 Da and a third at ∼28 600 Da). Therefore, an obvious increase of the molecular
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FIG. 1. (a) Chemical formula of the thioctic bidentate zwitterionic ligand Zw. (b) Deconvoluted ESI-MS spectra of Au:Zw
1:1, Au:Zw 1:2, and Au:Zw 1:5. (c) Concentration of gold (atomic%) with respect to the total concentration of sulphur (Stotal)
or to the concentration of sulphur bound to gold, carbon, and thiol (S–Au + S–C + S–H) from Zw extracted from XPS
measurements.
weight of Au NCs occurs when the ligand content increases as previously reported.28 However in this
study, we obtain a higher resolution in terms of size distribution thanks to the presence of an “enve-
lope” of peaks in the spectrum and the multiplicative correlation algorithm designed to enhance the
deconvoluted signal originated from the NCs. XPS experiments provide information about the atomic
concentration of each element and the nature of interaction within the sample. Contribution of gold
from the core bound directly to Zw via thiol groups and compared to the total amount of the ligand
could be followed by looking at the binding energy of S 2p, in particular the component at 161.8 eV
characteristic for S-Au (Figure S3 of the supplementary material). In Figure 1(c), the ratio of gold
concentration to the total concentration of sulphur (Au/Stotal) or to the concentration of sulphur bound
to gold, hydrogen, and carbon (Au/(S–Au + S–C + S–H)) indicates a constant decrease when Zw
increases. This behavior confirms that Zw continues to bind Au core even at the molar ratio Au:Zw
= 1:5. AunZwm stoichiometry is then evaluated based on the average mass estimated with deconvo-
luted ESI mass spectra and XPS results (giving access to Au/S ratio). Results show m > n by a factor
m/n higher than 2 for Au:Zw 1:1, Au:Zw 1:2, and Au:Zw 1:5, which is different, for instance, from
the one reported for thiolated-protected clusters using glutathione.4 Thus, the formation of Au:Zw
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could be seen rather like an organic charged layer coated onto ultra-small gold particles. The high
reactivity of the bidentate thioctic group of Zw to control Au NC growth and the strong electrostatic
interaction between sulfonate and ammonium in Zw might prevent the identification of magic size
“superatom”.
Absorbance measurements of Au:Zw sols show the standard plasmonic band at λ = 520 nm for
Au:Zw 5:1 and Au:Zw 2:1 and usually observed for Au NPs with size above 3 nm.1 Increase of
the ligand content during the synthesis leads to the fall of the plasmonic band with a decrease of
the UV band absorption (Figure S4 of the supplementary material). We can see an isobectic point
at λ = 420 nm between Au:Zw 1:2 and Au:Zw 1:5 that could be attributed to the absorption of
the ligand Zw in the UV-visible region.28 Fluorescence (Figure S5 of the supplementary material)
is strongly enhanced when Zw > Au with a rise at λ = 820 nm followed up by a blue-shift to
λ = 750 nm like it was previously reported.28 Plasmonic NPs exhibit very weak or no fluorescence.43
However, Au:Zw 2:1 sample still presents some fluorescence signal despite the presence of a plasmon
band. This effect could be related either to the presence of smaller NCs observed in high-resolution
transmission electron microscopy (HRTEM) that cannot be separated to the NPs in the solution due to
the low variation in weight or to the weak quenching effect of plasmonic NP due to the small particle
size.
Fluorescence intensity of the aqueous Au:Zw sols (2 mg gold/ml) prepared at different molar
ratios of Au:Zw was measured on a NIR 2D-fluorescence reflectance imaging device (λexc. 780 nm;
long pass (LP) 830 nm). This medical device is dedicated to non-invasive or intraoperative in vivo
imaging and has been used to guide surgical procedures.44,45 Phantom imaging illustrated in Figure
2(a) shows an exponential enhancement of the fluorescence intensity when increasing Zw content
with the highest signal for Au:Zw 1:5, which is in agreement with the fluorescence measurements
obtained on the spectrofluorimeter. The same trend is observed with a series of dilution up to 100 µg
gold/ml from the concentrated Au:Zw sols to insure no self-absorption in this concentration window.
FIG. 2. (a) Fluorescence intensity of Au:Zw sols (2 mg gold/ml) measured with a NIR 2D-fluorescence reflectance imaging
device (λexc. 780 nm; LP 830 nm). Photoacoustic signal of Au:Zw sols (2 mg gold/ml) (b) between 690 and 970 nm and (c)
at λexc. 710 nm. (d) Normalized fluorescence and photoacoustic signals for Au:Zw (2 mg gold/ml).
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Photoacoustic signal of the different Au:Zw sols exhibit a similar profile (Figure 2(b)) with a
constant decrease of the intensity at longer wavelength from 680 nm to 910 nm followed by a slight
augmentation until λ = 930 nm and then decreases again. In Figure 2(c), photoacoustic signal of
Au:Zw is plotted by fixing the wavelength at λ = 710 nm and drops drastically when Zw content
increased especially between Au:Zw 2:1 and Au:Zw 1:1. Evolution of normalized fluorescence and
photoacoustic signals is illustrated in Figure 2(d) and shows an opposite trend with a stronger flu-
orescent signal for Au:Zw 1:5 whereas Au:Zw 5:1 exhibits the highest photoacoustic signal. This
observation could be logically explained by the fact that high ligand coverage surrounding the metal
core of the NCs improves the rigidity of the network leading to a strong fluorescence intensity.46
Inversely, particle with a bigger metal core like for Au:Zw 2:1 and Au:Zw 5:1 with size > 4 nm will
produce heat under illumination leading to more intense vibration and then stronger photoacoustic
signal.
We then decided to select the sample Au:Zw 1:2 as the optimal candidate for in vitro and in
vivo experiments because it exhibits both quite intense fluorescence and enough signal to be detected
by PAI. Knowing the molecular weight of Au:Zw 1:2 ∼17 kDa, and the weight concentration of
gold per sample (∼50%), Au:Zw concentration could be then expressed in M (mol/l) in this study.
Fluorescence calibration of Au:Zw 1:2 between 4.5 µM and 600 µM suggests a limit of detection to
2.3 µM by fixing a signal/noise = 2 using PBS solution as control (Figure 3(a)). This sensitivity can
be considered as relatively high taking account of the low absorption of Au NCs at this excitation
wavelength (see absorbance and fluorescence emission Figures S4 and S5). Photoacoustic calibration
in Figure 3(b) indicates a linear behaviour between 70 and 600 µM with signal >0.2 at 140 µM.
In vitro cell studies have been performed on glioblastoma cells in culture (U87MG) incubating
those cells with Au:Zw 1:2 at 35 µM in complete medium during 4, 8, or 24 h. Flow cytometry analysis
illustrated in Figure 4(a) indicates an enhancement of the fluorescent signal in cells originated from
the Au NCs over time (quantification reported in Figure 4(c)) reaching more than 90% after 24 h
of incubation. Experiment performed at 4 ◦C shows a very weak Au NC uptake in cells after 4 h
of incubation with less than 5% positive cells compared to the same experiment set at 37 ◦C with
20.96% positive cells. This result confirms the low passive diffusion of those particles suggesting
that Au:Zw 1:2 probably accumulates on the cell surface before an uptake by active process.29,30,47
Cytotoxicity assays have been performed using propidium iodide (Figures 4(b) and 4(c)) and show
no significant toxicity (<3%) until 24 h incubation and even using Au NC concentration up to
100 µM (data no shown).
FIG. 3. (a) Calibration of Au:Zw 1:2 fluorescence intensity between 4.5 and 600 µM in water measured with a NIR 2D-
fluorescence reflectance imaging device (λexc. 780 nm; LP 830 nm). (b) Calibration of Au:Zw 1:2 photoacoustic signal
between 70 and 600 µM in water.
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FIG. 4. ((a) and (c)) Flow cytometry results and ((b) and (c)) toxicity tests by propidium iodide on U87MG cells incubated
with Au:Zw 1:2 (35 µM in complete medium) at different time points and at 37 ◦C and at 4 ◦C for 4 h.
Blood pharmacokinetic of Au:Zw 1:2 (M∼17 kDa; 600 µM in PBS) was measured by fluores-
cence imaging and shows a rapid clearance with an estimated half-life t1/2α = 6.5 ± 1.3 min from
a one compartment modelization. Wash out from blood is even faster using the well-characterized
Au25GSH18 (M∼11 kDa)31 in the same condition with t1/2α = 1.2± 0.2 min. Those estimated half-life
values are in the same order than previous in vivo studies using Au NCs stabilized by the tripeptide
glutathione (GSH) reported by Zheng’s team with t1/2α = 5.4± 1.2 min with a NC size of 40 kDa8 and
by Chen et al. with t1/2α = 0.7± 0.1 min.6 This indicates first that reducing particle’s size drastically
shortens the blood circulation and suggests also that the zwitterionic ligand Zw coated on Au NCs
leads to a longer blood circulation than GSH looking at the entire particle size. Non-invasive in vivo
fluorescence imaging confirms the high renal clearance with the strong accumulation of Au:Zw 1:2
FIG. 5. (a) Blood pharmacokinetic of Au:Zw 1:2 and Au25GSH18 after intravenous injection (200 µL; 600 µM). Au NC
concentration is determined from the fluorescence intensity values. (b) Non-invasive in vivo 2D fluorescence imaging 1 h after
intravenous injection of Au:Zw 1:2 (600 µM, V = 200 µL) illustrating the strong elimination of Au NC by the bladder.
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FIG. 6. Kinetic of Au:Zw 1:2 uptake in liver by (a) fluorescence and (b) photoacoustic imaging. (c) Non-invasive in vivo
fluorescence (left) and (d) photoacoustic (right) imaging 3 h after Au:Zw 1:2 intravenous injection (200 µL; 600 µM). (e)
Biodistribution analysis from ex vivo fluorescence imaging in different organs 1 h, 5 h, and 24 h after Au NC intravenous
injection (200 µL; 600 µM).
in the bladder 1 h after intravenous injection (Figure 5(b)) in the same way that it was observed for
others Au NCs.6,7
We evaluated the biodistribution of Au:Zw 1:2 in liver by using fluorescence imaging (Figures
6(a), 6(c), and 6(e)) and PAI (Figures 6(b), 6(d), and 6(e)) 1, 3, 5, and 24 h after intravenous injection.
We found a good agreement between these two imaging techniques indicating an early accumulation
of the Au NCs in the liver between 1 and 3 h followed by a slow elimination until 24 h. Mice were
sacrificed at 1, 5, and 24 h and biodistribution analysis from ex vivo fluorescence imaging illustrated
in Figure 6(e) shows the early elimination by kidney and bladder at 1 h post-injection which confirms
the efficiency of kidney filtration for those Au NCs. The ex vivo data also indicate a weak fluores-
cence signal from all the other organs with the exception of the liver presenting an early uptake of
Au NCs.
Herein, we demonstrate the ability to track gold nanoclusters (Au NCs) in vivo by two differ-
ent imaging techniques based on 2D-NIR fluorescence and photoacoustic signal. Au NCs stabilized
by a zwitterionic ligand could be synthesized by finely tuning the metal core size/ligand cover-
age in order to provide the best compromise fluorescence/photoacoustic signals. Those Au NCs
displayed high renal clearance and both imaging techniques indicate an early Au NC uptake in
liver. Therefore, the low toxicity and the detection of Au NCs by fluorescence imaging in the NIR
region and by photoacoustic imaging make those contrast agents highly promising for future in vivo
studies.
See supplementary material for the physico-chemical (TEM, XPS, ESI-MS) and optical
(absorbance, fluorescence) properties of Au NCs.
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